Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

Share Price is delayed by 15 minutes
Get Live Data
63.50    0.50 (0.79%)
Bid:
62.00
Ask:
65.00
Spread: 3.00 (4.839%)
Market Cap: £60.18m
TPX Live PriceLast checked at - London Stock Exchange

Intraday Tpximpact Hldg Share Chart

Contract wins and update on Foundry4

4 Feb 2021 07:00

RNS Number : 9322N
Panoply Holdings PLC (The)
04 February 2021
 

4 February 2021

 

The Panoply Holdings PLC

("The Panoply", or the "Group")

 

Contract wins and update on Foundry4

The Panoply Holdings PLC (AIM: TPX), the technology-enabled services group focused on digital transformation, announces it has recently won two separate contracts in partnership with Mastek, a global IT player, worth more than £7m over the life of the contracts (the "Contracts").

 

Contract wins

 

The Contracts, which run for two years and have been awarded by the NHS Business Services Authority, comprise a £6m framework agreement to provide capabilities to support the organisation's digital transformation agenda and a £1.2m contract to be its overseas digital health delivery partner.

 

Update on Foundry4

 

The Group is pleased to announce that Difrent will be integrated into Foundry4 with effect from 1 April 2021 at which time Rachel Murphy, current CEO of Difrent, will become CEO of Foundry4. Rachel brings a wealth of delivery experience from across the public sector and the healthcare market, providing the foundations for further expansion into this target market for the Group.

 

James Herbert, the current CEO of Foundry4, will take on the role of Strategic Partnerships Director, responsible for the Group's relationships with Microsoft, Amazon (AWS) and Google (GCP). Foundry4's relationships with these key technology platforms are critical to its success. Foundry4 recently attained a Microsoft Gold Cloud Platform competency, demonstrating a "best-in-class" ability and commitment to meet Microsoft Corp. customers' evolving needs in today's mobile-first, cloud-first world as well as distinguishing itself within Microsoft's partner ecosystem. Becoming a Microsoft Gold Partner will allow Foundry4 to combine strengths with Microsoft, speeding up deployment and improvement of Microsoft Azure environments.

 

Neal Gandhi, CEO of The Panoply, said:

 

"These contract wins represent a step-change in our reach into healthcare, a key growth sector for the Group. We look forward to working with Mastek to support the NHS BSA with its ongoing digital transformation agenda.

 

We are also delighted that Difrent, the company whose approach has so impressed to secure these wins, will be joining our Foundry4 brand and that Rachel Murphy will be leading it forward as CEO. With her extensive experience driving digital change, Foundry4 is well placed to strengthen its reputation as a leading provider in digital transformation across the public and private sectors."

 

Rachel Murphy, CEO designate of Foundry4 said:

 

"Even from Difrent's relatively short time as part of the Group, the substantial opportunities available through collaboration and combination among the different businesses is clear.

 

In my role as CEO of Foundry4, I am excited to leverage the varied skills and technical expertise we have in our possession to expand the Group's reach across the markets in which we operate".

 

 

Enquiries:

 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited

(Nomad and Joint Broker)

 

Via Alma PR

 

 

+44 (0)207 710 7600

Fred Walsh

Alex Price

 

Dowgate Capital Limited

(Joint Broker)

James Serjeant

David Poutney

 

 

+44 (0)203 903 7715

Alma PR

(Financial PR)

Susie Hudson

Josh Royston

Harriet Jackson

panoply@almapr.co.uk

+44 (0)203 405 0205

 

 

 

 

About The Panoply

 

The Panoply is a technology-enabled services group, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology, design and innovation consulting businesses, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

The Group is being increasingly recognised as a leading alternative digital transformation provider to the UK public services sector, with c.70% of its client base representing the public sector and c.30% representing the commercial sector.

More information is available at www.thepanoply.com

 

About Foundry4

 

Foundry4 helps organisations in highly regulated sectors harness technology to solve complex challenges. Its deep technical expertise covers all areas of the digital spectrum, from intelligent automation and user centred design, to high quality product engineering teams and agile coaching.

 

Partnering with enterprise organisations, Foundry4 draw on extensive technology and sector knowledge to help them harness the true value of cloud and data.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTBIGDDXDGDGBX
Date   Source Headline
16th Jun 20267:00 amRNSUnaudited preliminary results
11th Jun 20267:00 amRNSShare Incentive Plan
1st Jun 20267:00 amRNSTPXimpact announces £16m contract with the MoJ
11th May 20267:00 amRNSShare Incentive Plan
22nd Apr 20267:00 amRNSFull Year Trading Update and Notice of Results
17th Apr 20264:17 pmRNSNotification of Major Holdings
17th Apr 20267:00 amRNSShare Incentive Plan
20th Mar 20267:00 amRNSShare Incentive Plan
24th Feb 20267:00 amRNSQ3 Trading Update: EBITDA guidance Upgrade
17th Feb 20267:00 amRNSContract Uplift
12th Feb 20267:01 amRNSTPXimpact announces £39m Contract with DEFRA
12th Feb 20267:00 amRNSShare Incentive Plan
11th Feb 20267:00 amRNSTPXimpact announces £22m NHS England contract
9th Jan 20267:00 amRNSShare Incentive Plan
9th Dec 20257:00 amRNSShare Incentive Plan
8th Dec 20255:19 pmRNSHolding(s) in Company
2nd Dec 20252:45 pmRNSExercise of Options, PDMR, & Total Voting Rights
2nd Dec 20257:00 amRNSUnaudited Interim Results
24th Nov 20257:30 amRNSAppointment of Nominated Adviser and Broker
14th Nov 20257:00 amRNSShare Incentive Plan
5th Nov 20257:00 amRNSFirst Half Update & Notice of Results
14th Oct 20255:29 pmRNSShare Incentive Plan
25th Sep 20254:37 pmRNSResult of AGM
9th Sep 20257:00 amRNSShare Incentive Plan
8th Sep 20255:25 pmRNSExercise of Options & PDMR Dealings
8th Sep 20253:27 pmRNSNotification of Major Holdings
5th Sep 202512:37 pmRNSIssuance of Shares & Total Voting Rights
22nd Aug 20257:00 amRNSNotice of AGM
21st Aug 20257:00 amRNSChange of Auditor
12th Aug 20256:05 pmRNSReplacement: FY25 & FY26 Share Awards
11th Aug 20257:00 amRNSPosting of Annual Report
4th Aug 20259:24 amRNSReplacement: FY25 & FY26 Share Awards
4th Aug 20257:00 amRNSFY25 & FY26 Long-Term Incentive Share Award
30th Jul 20257:00 amRNSDebt Facility Renewal Update
14th Jul 20257:00 amRNSAppointment of non-executive director
10th Jul 20257:00 amRNSShare Incentive Plan
24th Jun 20257:00 amRNSUnaudited preliminary results
16th Jun 20259:00 amRNSNotice of Results
12th Jun 20251:17 pmRNSShare Incentive Plan
14th May 20257:00 amRNSTrading Update and Contract Wins
22nd Apr 20257:00 amRNSResignation of Non-Executive Director
11th Apr 20257:00 amRNSShare Incentive Plan
12th Mar 20257:00 amRNSShare Incentive Plan
28th Feb 20253:26 pmRNSChange of Registered Office Address
12th Feb 20257:00 amRNSShare Incentive Plan
6th Feb 20257:00 amRNSQ3 Trading Update and Revised Outlook
3rd Feb 20257:00 amRNSConfirmation of CFO Appointment
15th Jan 20257:00 amRNSShare Incentive Plan
18th Dec 20247:00 amRNSDirectorate Change - Group CFO retirement
11th Dec 20247:00 amRNSShare Incentive Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.